Ain Raal | Herbal Medicine and Nutraceuticals | Editorial Board Member

Editorial Board Member

Ain Raal, University of Tartu, Estonia

Ain Raal
Affiliation University of Tartu
Country Estonia
Scopus ID 6505977002
Documents 2600
Citations 3199
h-index 30
Subject Area Herbal Medicine and Nutraceuticals
Event International Top Pharmaceutical Awards
ORCID 0000-0001-8731-7366

Ain Raal is associated with the University of Tartu in Estonia and is recognized for contributions to the field of herbal medicine, pharmacognosy, and nutraceutical sciences. His scholarly activities have focused on medicinal plants, natural products research, phytotherapy, and evidence-based applications of traditional remedies in pharmaceutical sciences.[1] The academic profile demonstrates extensive publication activity, interdisciplinary collaboration, and continued engagement with pharmaceutical and botanical research communities.[2]

Abstract

This article presents a scholarly overview of Ain Raal and his academic association with the University of Tartu. The profile highlights contributions to herbal medicine, medicinal plant research, nutraceutical sciences, and pharmaceutical education. Research activities include phytochemical evaluation, traditional medicine documentation, and evidence-based applications of natural products within pharmaceutical practice.[2] The article further summarizes publication activity, research influence, and academic relevance within contemporary pharmaceutical and botanical sciences.[3]

Keywords

Herbal Medicine, Nutraceuticals, Pharmacognosy, Medicinal Plants, Phytotherapy, Natural Products, Pharmaceutical Sciences, Traditional Medicine, University of Tartu, Estonia

Introduction

The study of herbal medicine and nutraceutical sciences has gained increasing importance within modern pharmaceutical research due to growing interest in evidence-based natural therapeutics and preventive healthcare strategies. Ain Raal has contributed to these fields through academic research, scientific publications, and participation in pharmaceutical education initiatives related to medicinal plants and pharmacognosy.[1] His association with the University of Tartu reflects engagement with interdisciplinary pharmaceutical sciences, including botanical medicine, phytochemistry, and natural product analysis.[4]

Research Profile

The academic profile of Ain Raal demonstrates sustained involvement in medicinal plant investigations and pharmaceutical sciences. His research interests include herbal therapeutics, traditional medicine validation, plant-derived bioactive compounds, and nutraceutical applications.[2] The documented publication record and citation metrics indicate long-term scholarly participation and recognition within pharmacognosy-related research communities.[1]

  • Research emphasis on herbal medicine and medicinal plants.
  • Academic involvement in nutraceutical and pharmaceutical sciences.
  • Contribution to evidence-based phytotherapy studies.
  • Participation in interdisciplinary scientific collaborations.

Research Contributions

Ain Raal has contributed to the scientific understanding of medicinal plants, phytotherapeutic compounds, and natural product applications in healthcare systems. Research contributions are associated with the documentation of traditional medicinal knowledge and the scientific assessment of herbal preparations.[3] These activities support broader pharmaceutical efforts aimed at integrating botanical resources into evidence-based healthcare frameworks.[5]

The publication activity also reflects engagement with pharmacognostic evaluation, herbal formulation studies, and natural product pharmacology. Such contributions are relevant to pharmaceutical innovation, nutraceutical product development, and public health research involving plant-derived therapeutics.[4]

Publications

Selected scholarly publications and indexed academic outputs associated with herbal medicine and pharmacognosy-related research include the following representative works.[2]

  • Research on medicinal plant applications in pharmaceutical sciences and herbal therapeutics.
  • Scientific investigations involving phytochemical and pharmacognostic evaluation of natural products.
  • Studies related to nutraceutical compounds and evidence-based herbal medicine.
  • Collaborative academic contributions within pharmaceutical and botanical research disciplines.

Research Impact

The research impact associated with Ain Raal is reflected through publication indexing, citation activity, and continuing scholarly relevance in herbal medicine and pharmaceutical sciences. Citation metrics and publication output indicate engagement with international research audiences and contribution to academic discourse related to medicinal plants and nutraceutical sciences.[1]

The h-index value and documented scholarly activity demonstrate sustained scientific productivity and influence within pharmacognosy-oriented literature. These metrics also indicate ongoing relevance in research areas connected to traditional medicine and natural product pharmacology.[5]

Award Suitability

The academic profile of Ain Raal aligns with recognition categories related to pharmaceutical sciences, herbal medicine, and nutraceutical research. The documented publication record, citation indicators, and sustained contributions to medicinal plant research demonstrate suitability for scholarly recognition within international pharmaceutical award platforms.[2]

The association with interdisciplinary pharmaceutical research and evidence-based herbal medicine further supports relevance to academic and professional recognition initiatives involving natural products and pharmacognosy research.[4]

Conclusion

Ain Raal represents an academic profile associated with sustained research activity in herbal medicine, medicinal plants, and nutraceutical sciences. The scholarly contributions, publication activity, and interdisciplinary pharmaceutical research engagement demonstrate continuing relevance within evidence-based natural product research. The documented academic indicators support recognition within pharmaceutical and pharmacognosy-related scientific communities.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Ain Raal, Author ID 6505977002. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=6505977002
  2. Raal, A. et al. (2019). Antihyperuricemic and xanthine oxidase inhibitory activities of Tribulus arabicus and its isolated compound, ursolic acid. PLOS ONE.
    DOI: https://doi.org/10.1371/journal.pone.0202572
  3. Raal, A. et al. (2017). Therapeutic potentials of Crataegus azarolus var. eu-azarolus Maire leaves and its isolated compounds. BMC Complementary and Alternative Medicine.
    DOI: https://doi.org/10.1186/s12906-017-1729-9
  4. Raal, A. et al. (2020). Micromeria fruticosa induces cell cycle arrest and apoptosis in breast and colorectal cancer cells. Pharmaceuticals.
    DOI: https://doi.org/10.3390/ph13060115
  5. Raal, A. et al. (2022). Metabolic and biotransformation effects on dietary glucosinolates, their bioavailability, catabolism and biological effects in different organisms. Biotechnology Advances.
    DOI: https://www.sciencedirect.com/science/article/abs/pii/S0734975021000902

Khalid M Alkharfy| Herbal Medicine and Nutraceuticals | Best Researcher Award

Prof. Dr. Khalid M Alkharfy| Herbal Medicine and Nutraceuticals | Best Researcher Award

King Saud University, Saudi Arabia

Author Profile

Early Academic Pursuits 🎓

Prof. Dr. Khalid M. Alkharfy began his academic journey with an unwavering commitment to pharmaceutical sciences. Graduating with class honors from King Saud University in 1992 with a Bachelor of Pharmaceutical Sciences (B.Sc. Pharm), he established a solid foundation for his future contributions to the field. His academic excellence continued as he pursued a Doctor of Pharmacy (Pharm.D) at the University of Tennessee, USA, graduating in 1997 with class honors. During this period, Dr. Alkharfy honed his skills as a pharmacy intern at leading healthcare institutions in Memphis, Tennessee, including Veterans Affairs Medical Center, Regional Medical Center, and Baptist Memorial Hospital. This formative training emphasized his proficiency in adjusting and monitoring drug therapies, providing patient counseling, and collaborating with multidisciplinary medical teams.

Furthering his expertise, Dr. Alkharfy earned a Doctor of Philosophy (Ph.D.) in Pharmaceutical Sciences from the University of Pittsburgh in 2002. This significant achievement, recognized with distinction in clinical research, underscored his ability to conduct groundbreaking studies and set the stage for his impactful career in clinical and translational research.

Professional Endeavors and Leadership 🏢

Dr. Alkharfy’s professional journey is characterized by a series of prominent leadership roles, showcasing his scientific acumen and administrative capabilities. Starting as a Clinical Instructor at King Khalid University Hospital (1992-1994), he contributed to training pharmacy students while working with the nephrology medical team. His academic and research career blossomed further during his tenure as a Research Associate (1997-2002) at the University of Pittsburgh Medical Center, where he played a pivotal role in designing and conducting clinical trials, analyzing data, and disseminating findings through conferences and publications.

Returning to Saudi Arabia, Dr. Alkharfy joined King Saud University in 2002 as a Professor of Clinical and Translational Research in the Department of Clinical Pharmacy. In this capacity, he has led numerous initiatives, including the Translational and Drug Discovery Unit and the Biomarkers Research Program, focusing on metabolic disorders and diabetes. His leadership extended beyond academia as he served as Dean of the College of Pharmacy at Prince Sattam University (2013-2016) and as the Founding Dean of Almaarefa University’s College of Pharmacy (2011-2013).Additionally, Dr. Alkharfy took on national responsibilities as a Consultant for the Saudi Food and Drug Authority (SFDA), advising on regulatory frameworks and ensuring pharmaceutical standards. His global contributions include Visiting Scholar positions at renowned institutions such as Mayo Clinic (USA), the University of Hong Kong, and Charles University (Czech Republic).

Contributions and Research Focus 🔬

Dr. Alkharfy has made profound contributions to clinical and translational research, with a focus on metabolic disorders, diabetes, and drug discovery. As a leader in the Biomarkers Research Program, he has designed innovative studies to identify novel therapeutic targets and biomarkers for chronic diseases. His expertise has also extended to creating an ecosystem for R&D projects as Director of Riyadh Techno Valley, where he fostered collaborations between academia, industry, and government to advance Saudi Arabia’s science and technology infrastructure.Dr. Alkharfy has authored and co-authored over 260 scientific papers, abstracts, and publications, many of which have appeared in high-impact, peer-reviewed journals. His work demonstrates a commitment to advancing global health through robust research methodologies and interdisciplinary collaboration.

Accolades and Recognition 🏆

Over the years, Dr. Alkharfy’s accomplishments have garnered international recognition. As a Fulbright Scholar at Mayo Clinic (2019), he contributed to advanced clinical research in diabetes and pharmacotherapy. His expertise earned him invitations to prestigious visiting scholar positions at leading universities worldwide, including the University of Campinas (Brazil), International Islamic University Malaysia, and the University of Auckland (New Zealand).Dr. Alkharfy’s innovation is further evidenced by his four registered patents across Saudi Arabia, the USA, and Europe, reflecting his commitment to translating research into tangible solutions. His leadership as Dean and consultant roles have been instrumental in shaping pharmacy education and regulatory practices in Saudi Arabia.

Impact and Influence 🌍

Dr. Alkharfy’s work has had a lasting impact on both academia and public health policy. As a leader in clinical and translational research, his studies on diabetes and metabolic disorders have influenced treatment paradigms, while his patents have contributed to drug discovery and development. His mentorship of young scientists and pharmacy students has inspired a new generation of researchers and clinicians in Saudi Arabia and beyond.

Through his roles in national regulatory bodies and academic institutions, Dr. Alkharfy has played a critical part in strengthening the research infrastructure in Saudi Arabia, promoting innovation, and aligning the country’s scientific endeavors with international standards.

Legacy and Future Contributions 🌟

As Dr. Khalid M. Alkharfy continues his illustrious career, his legacy is firmly rooted in his dedication to research excellence, leadership, and education. His work has set a benchmark for integrating clinical and translational research with public health initiatives, fostering international collaborations, and nurturing talent in pharmaceutical sciences.

📖Notable Publications

Effect of physical activity and sun exposure on vitamin D status of Saudi children and adolescents
  • Authors : Abdulaziz Al-Othman, Sara Al-Musharaf, Nasser M Al-Daghri, Soundararajan Krishnaswamy, Deqa S Yusuf, Khalid M Alkharfy, Yousef Al-Saleh, Omar S Al-Attas, Majed S Alokail, Osama Moharram, Shaun Sabico, George P Chrousos
  • Journal: BMC pediatrics
  • Year: 2012
Association of VDR-gene variants with factors related to the metabolic syndrome, type 2 diabetes and vitamin D deficiency
  • Authors : Nasser M Al-Daghri, Omar S Al-Attas, Khalid M Alkharfy, Nasiruddin Khan, Abdul Khader Mohammed, Benjamin Vinodson, Mohammed Ghouse Ahmed Ansari, Amal Alenad, Majed S Alokail
  • Journal: Gene
  • Year: 2014
Momordica charantia polysaccharides ameliorate oxidative stress, inflammation, and apoptosis in ethanol-induced gastritis in mucosa through NF-kB signaling pathway inhibition
  • Authors : Mohammad Raish, Ajaz Ahmad, Mushtaq Ahmad Ansari, Khalid M Alkharfy, Fahad I Aljenoobi, Basit L Jan, Abdullah M Al-Mohizea, Altaf Khan, Naushad Ali
  • Journal: Biological Macromolecules
  • Year: 2018
Irisin as a predictor of glucose metabolism in children: sexually dimorphic effects
  • Authors : Nasser M Al‐Daghri, Khalid M Alkharfy, Shakilur Rahman, Osama E Amer, Benjamin Vinodson, Shaun Sabico, Milan K Piya, Alison L Harte, Philip G McTernan, Majed S Alokail, George P Chrousos
  • Journal: European Journal of Clinical Investigation
  • Year: 2014
Application of Box–Behnken design for ultrasonic-assisted extraction of polysaccharides from Paeonia emodi
  • Authors : Ajaz Ahmad, Khalid M Alkharfy, Tanveer A Wani, Mohammad Raish Ansari; Muzaffar Iqbal; Ali N; Alkharfy KM et al.
  • Journal:biological macromolecules
  • Year: 2015